![Igor Gorbatchevsky](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Igor Gorbatchevsky is currently Chief Medical Officer at Celcuity, Inc. since 2021.
Former positions include Vice President-Clinical Development at Lite Strategy, Inc. from 2019 to 2021, Vice President-Clinical Science at Iovance Biotherapeutics, Inc. from 2017 to 2018, and Senior Medical Director at Daiichi Sankyo Co., Ltd. from 2009 to 2014.
Igor Gorbatchevsky active positions
| Companies | Position | Start |
|---|---|---|
| CELCUITY INC. | Chief Tech/Sci/R&D Officer | 09/06/2021 |
Former positions of Igor Gorbatchevsky
| Companies | Position | End |
|---|---|---|
| LITE STRATEGY, INC. | Corporate Officer/Principal | 01/06/2021 |
| IOVANCE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/07/2018 |
| DAIICHI SANKYO COMPANY, LIMITED | Chief Tech/Sci/R&D Officer | 01/01/2014 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
37
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
MEI Pharma, Inc.
 MEI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Daiichi Sankyo Co., Ltd.
 Daiichi Sankyo Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the manufacture and sale of pharmaceutical products | Health Technology |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Celcuity, Inc.
 Celcuity, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company develops novel diagnostic tests | Health Technology |
- Stock Market
- Insiders
- Igor Gorbatchevsky
